Trials / Completed
CompletedNCT00027794
Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer
Radical Prostatectomy for Locally Advanced Prostate Cancer. A Feasibility Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC · Network
- Sex
- Male
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Radical prostatectomy may be an effective treatment for locally advanced prostate cancer. PURPOSE: Phase II trial to study the effectiveness of radical prostatectomy in treating patients who have locally advanced prostate cancer.
Detailed description
OBJECTIVES: * Determine the success rate of radical prostatectomy in patients with locally advanced adenocarcinoma of the prostate. * Determine the serious toxic event rate of this surgery in these patients. * Determine the pN status of patients treated with this surgery. * Determine the percentage of patients found to have organ-confined tumors (pT2) after undergoing this surgery. * Determine the 2-year prostate-specific antigen-free survival rate of patients treated with this surgery. * Determine the surgical morbidity rates of patients treated with this surgery. OUTLINE: This is a multicenter study. Patients undergo limited pelvic lymphadenectomy and then radical retropubic prostatectomy. Patients who are found to have pN-positive disease receive further treatment according to the investigator's discretion. Patients with pN0 disease are followed every 3 months for 1 year and then every 4 months for 1 year. PROJECTED ACCRUAL: A total of 32-74 patients will be accrued for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | conventional surgery |
Timeline
- Start date
- 2001-09-01
- Primary completion
- 2005-01-01
- First posted
- 2003-01-27
- Last updated
- 2012-09-24
Locations
5 sites across 3 countries: Belgium, Italy, Slovakia
Source: ClinicalTrials.gov record NCT00027794. Inclusion in this directory is not an endorsement.